Your browser doesn't support javascript.
loading
NUP214 fusion genes in acute leukemias: genetic characterization of rare cases.
Brunetti, Marta; Andersen, Kristin; Spetalen, Signe; Lenartova, Andrea; Osnes, Liv Toril Nygård; Vålerhaugen, Helen; Heim, Sverre; Micci, Francesca.
Afiliação
  • Brunetti M; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Andersen K; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Spetalen S; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Lenartova A; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Osnes LTN; Department of Haematology, Oslo University Hospital, Oslo, Norway.
  • Vålerhaugen H; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Heim S; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Micci F; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Front Oncol ; 14: 1371980, 2024.
Article em En | MEDLINE | ID: mdl-38571499
ABSTRACT

Introduction:

Alterations of the NUP214 gene (9q34) are recurrent in acute leukemias. Rearrangements of chromosomal band 9q34 targeting this locus can be karyotypically distinct, for example t(6;9)(p22;q34)/DEKNUP214, or cryptic, in which case no visible change of 9q34 is seen by chromosome banding.

Methods:

We examined 9 cases of acute leukemia with NUP214 rearrangement by array Comparative Genomic Hybridization (aCGH), reverse-transcription polymerase chain reaction (RT-PCR), and cycle sequencing/Sanger sequencing to detect which fusion genes had been generated.

Results:

The chimeras DEKNUP214, SETNUP214, and NUP214ABL1 were found, only the first of which can be readily detected by karyotyping.

Discussion:

The identification of a specific NUP214 rearrangement is fundamental in the management of these patients, i.e., AMLs with DEKNUP214 are classified as an adverse risk group and might be considered for allogenic transplant. Genome- and/or transcriptome-based next generation sequencing (NGS) techniques can be used to screen for these fusions, but we hereby present an alternative, step-wise procedure to detect these rearrangements.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article